Kymera Therapeutics, Inc. (KYMR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 37.40 |
| Open | 37.71 |
| Bid | 38.25 x 300 |
| Ask | 38.35 x 200 |
| Day's Range | 37.19 - 38.52 |
| 52 Week Range | 9.60 - 45.31 |
| Volume | |
| Avg. Volume | 625,215 |
| Market Cap | 2.35B |
| Beta (5Y Monthly) | 2.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.51 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.71 |
Simply Wall St.Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
It's been a pretty great week for Kymera Therapeutics, Inc. ( NASDAQ:KYMR ) shareholders, with its shares surging 12...
Insider MonkeyKymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript May 3, 2024 Kymera Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Kymera Therapeutics First Quarter 2024 Results Conference Call. All participants will […]
ZacksKymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Kymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the current cash balance to provide a runway into the first half of 2027.
© 2024 Yahoo. All rights reserved.